| 000 | 01578 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511224034.0 | ||
| 264 | 0 | _c19900816 | |
| 008 | 199008s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/ijc.2910460112 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsuboi, R | |
| 245 | 0 | 0 |
_aBimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJul 1990 |
||
| 300 |
_a56-60 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAmnion _xdrug effects |
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 |
_aBiological Assay _xmethods |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aFibrinolysin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlycoproteins _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aMelanoma _xmetabolism |
| 650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _ximmunology |
| 650 | 0 | 4 |
_aPlasminogen Activators _ximmunology |
| 650 | 0 | 4 | _aTissue Inhibitor of Metalloproteinases |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _ximmunology |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _ximmunology |
| 700 | 1 | _aRifkin, D B | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 46 _gno. 1 _gp. 56-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.2910460112 _zAvailable from publisher's website |
| 999 |
_c2148289 _d2148289 |
||